VRTX: Garber Alan M reports a stock award
By AlphaYouPublished Form 4
Garber Alan M
Reporting filer
Garber Alan M reports a stock award, not an open-market purchase or sale, in Vertex Pharmaceuticals Inc / Ma. Form 4 filed Oct 19, 2026 lists 1 entry.
- Disclosed
- Oct 19, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock Units (derivative) | Garber Alan M | 2026-10-15 | A | Grant or award | 29.272 | 512.44 | 94.73 | 4 days | Filed terms
|
Deferred Stock Units (derivative)
- Owner
- Garber Alan M
- Date
- 2026-10-15
- Code
- A
- Action
- Grant or award
- Quantity
- 29.272
- Price
- 512.44
- Following holdings
- 94.73
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Deferred Stock Units
- id: F1
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 29.272
- transaction Price Per Share: 512.44
- transaction Acquired Disposed Code: A
- id: F1
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 29.272
- shares Owned Following Transaction: 94.73
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Garber Alan M: Director.
- F1: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.
Original sources
Prepared automatically from public filing data. Report a correction.